These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16541065)

  • 1. Robust Salmonella metabolism limits possibilities for new antimicrobials.
    Becker D; Selbach M; Rollenhagen C; Ballmaier M; Meyer TF; Mann M; Bumann D
    Nature; 2006 Mar; 440(7082):303-7. PubMed ID: 16541065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do targets limit antibiotic discovery?
    Schmid MB
    Nat Biotechnol; 2006 Apr; 24(4):419-20. PubMed ID: 16601725
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. System-level analysis of Salmonella metabolism during infection.
    Bumann D
    Curr Opin Microbiol; 2009 Oct; 12(5):559-67. PubMed ID: 19744878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
    Uddin R; Sufian M
    PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics analysis of the causative agent of typhoid fever.
    Ansong C; Yoon H; Norbeck AD; Gustin JK; McDermott JE; Mottaz HM; Rue J; Adkins JN; Heffron F; Smith RD
    J Proteome Res; 2008 Feb; 7(2):546-57. PubMed ID: 18166006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functional interface between Salmonella and its host cell: opportunities for therapeutic intervention.
    Patel JC; Rossanese OW; Galán JE
    Trends Pharmacol Sci; 2005 Nov; 26(11):564-70. PubMed ID: 16182381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food animal-associated Salmonella challenges: pathogenicity and antimicrobial resistance.
    Foley SL; Lynne AM
    J Anim Sci; 2008 Apr; 86(14 Suppl):E173-87. PubMed ID: 17878285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogen proteomes during infection: A basis for infection research and novel control strategies.
    Bumann D
    J Proteomics; 2010 Oct; 73(11):2267-76. PubMed ID: 20797457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a transcriptional regulator that controls intracellular gene expression in Salmonella Typhi.
    Haghjoo E; Galán JE
    Mol Microbiol; 2007 Jun; 64(6):1549-61. PubMed ID: 17555437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Has nature already identified all useful antibacterial targets?
    Bumann D
    Curr Opin Microbiol; 2008 Oct; 11(5):387-92. PubMed ID: 18804175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic resistance, integrons and Salmonella genomic island 1 among non-typhoidal Salmonella serovars in The Netherlands.
    Vo AT; van Duijkeren E; Fluit AC; Wannet WJ; Verbruggen AJ; Maas HM; Gaastra W
    Int J Antimicrob Agents; 2006 Sep; 28(3):172-9. PubMed ID: 16911867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic sensitivity profiles of salmonella organisms isolated from presumptive typhoid patients in Zaria, northern Nigeria.
    Ibrahim YK; Adedare TA; Ehinmidu JO
    Afr J Med Med Sci; 2005 Jun; 34(2):109-14. PubMed ID: 16749332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commonly used farm disinfectants can select for mutant Salmonella enterica serovar Typhimurium with decreased susceptibility to biocides and antibiotics without compromising virulence.
    Randall LP; Cooles SW; Coldham NG; Penuela EG; Mott AC; Woodward MJ; Piddock LJ; Webber MA
    J Antimicrob Chemother; 2007 Dec; 60(6):1273-80. PubMed ID: 17897935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of porcine transcriptional response to Salmonella enterica serovar Choleraesuis suggests novel targets of NFkappaB are activated in the mesenteric lymph node.
    Wang Y; Couture OP; Qu L; Uthe JJ; Bearson SM; Kuhar D; Lunney JK; Nettleton D; Dekkers JC; Tuggle CK
    BMC Genomics; 2008 Sep; 9():437. PubMed ID: 18811943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evolutionary engineering in Salmonella: emergence of hybrid virulence-resistance plasmids in non-typhoid serotypes].
    Mendoza Mdel C; Herrero A; Rodicio MR
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):37-43. PubMed ID: 19218002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance in non-typhoidal Salmonella from human sources, Spain, 2001-2003.
    Soler P; González-Sanz R; Bleda MJ; Hernández G; Echeíta A; Usera MA
    J Antimicrob Chemother; 2006 Aug; 58(2):310-4. PubMed ID: 16735424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel exploitation of diverse host nutrients enhances Salmonella virulence.
    Steeb B; Claudi B; Burton NA; Tienz P; Schmidt A; Farhan H; Mazé A; Bumann D
    PLoS Pathog; 2013; 9(4):e1003301. PubMed ID: 23633950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreasing prevalence of antimicrobial resistance in non-typhoidal Salmonella isolated from children with bacteraemia in a rural district hospital, Kenya.
    Kariuki S; Revathi G; Kiiru J; Lowe B; Berkley JA; Hart CA
    Int J Antimicrob Agents; 2006 Sep; 28(3):166-71. PubMed ID: 16904874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular evolution of Salmonella enterica serovar Typhimurium and pathogenic Escherichia coli: from pathogenesis to therapeutics.
    Lavigne JP; Blanc-Potard AB
    Infect Genet Evol; 2008 Mar; 8(2):217-26. PubMed ID: 18226587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.